TRIP13 and breast cancer: From the analysis of BC datasets in the Oncomine and UALCAN databases, TRIP13 was found to be highly expressed in BC tumour tissue compared with normal controls (Figures 1 and 2), an observation validated by IHC analysis of physical samples from our BC patients (Figure 3A).